TBPH icon

Theravance Biopharma

98 hedge funds and large institutions have $793M invested in Theravance Biopharma in 2019 Q2 according to their latest regulatory filings, with 11 funds opening new positions, 38 increasing their positions, 21 reducing their positions, and 15 closing their positions.

New
Increased
Maintained
Reduced
Closed

more repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

more ownership

Funds ownership:

more funds holding in top 10

Funds holding in top 10:

less funds holding

Funds holding:

27% less first-time investments, than exits

New positions opened: 11 | Existing positions closed: 15

28% less capital invested

Capital invested by funds: $1.1B → $793M (-$306M)

87% less call options, than puts

Call options by funds: $2.26M | Put options by funds: $17.3M

Holders
98
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$2.26M
Puts
$17.3M
Net Calls
Net Calls Change

Top Buyers

1 +$7.54M
2 +$4.21M
3 +$3.61M
4
JG
Jefferies Group
New York
+$3.52M
5
Nomura Holdings
Nomura Holdings
Japan
+$2.54M
Name Holding Trade Value Shares
Change
Change in
Stake
1
$199M
2
$152M
3
$135M
4
$64.2M
5
$62.6M
6
$18.6M
7
$15.3M
8
$15.2M
9
$9.56M
10
$9.13M
11
$9.04M
12
$8.98M
13
$8.96M
14
$7.54M
15
$5.53M
16
$5.06M
17
$5.02M
18
$4.55M
19
$4.33M
20
$4.12M
21
$4M
22
$3.61M
23
$3.56M
24
$3.39M
25
$2.97M